260
Participants
Start Date
June 3, 2019
Primary Completion Date
September 11, 2020
Study Completion Date
September 11, 2020
gadopiclenol
single intravenous (IV) bolus injection at a rate of 2ml/second
Gadobutrol 1Mmol/mL Solution for Injection Vial
single intravenous (IV) bolus injection at a rate of 2ml/second
Semmelweis Egyetem - Neurology, Budapest
UZ Brussel - Campus Jette, Brussels
Orszagos Klinikai Idegtudomanyi Intezet, Budapest
Asan Medical Center, Seoul
Szegedi Tudomanyegyetem AOK, Szeged
Taipei Veterans General Hospital, Taipei
University Of Pennsylvania, Philadelphia
Fondazione I.R.C.C.S. C.Mondino, Pavia
M.D. Anderson Cancer Center Madrid, Madrid
Hospital Clínico San Carlos, Madrid
South Carolina Clinical & Translational Research (SCTR) Institute, Charleston
Azienda Sanitaria Universitaria Integrata di Trieste-PO Cattinara, Trieste
Clinical Research Institute S.C, Tlalnepantla
Northwestern Memorial Hospital, Chicago
Axis Heilsa S. de R.L. de C.V. (Althian), Monterrey
University of Missouri Hospital and Clinic, Columbia
CHRU Strasbourg Hôpital de Hautepierre, Strasbourg
Uniklinik Mannheim, Mannheim
Centre Hospitalier Sainte-Anne, Paris
Istituto Neurologico Mediterraneo-Neuromed, I.R.C.C.S., Pozzilli
ASCLEPES Research Centers, Panorama City
University Of Washington - Medical Center, Seattle
Northwest Neurology, Ltd., Rolling Meadows
University of Connecticut Health Center, Farmington
ZNA Middelheim, Antwerp
CHRU - Hôpital Roger Salengro - Neurologie, Lille
CHU La Miletrie, Poitiers
Debreceni Egyetem Klinikai Kozpont, Debrecen
ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila, Ospedale Regionale San Salvatore, L’Aquila
Pecsi Tudomanyegyetem Klinikai Kozpont - Idegsebeszeti Klinika, Pécs
Uniwersyteckie Centrum Kliniczne w Gdańsku, Zakład Radiologii, Gdansk
Konkuk University Medical Center, Seoul
Hospital del Mar, Barcelona
Lead Sponsor
Guerbet
INDUSTRY